Individual hearts: computational models for improved management of cardiovascular disease

Nick van Osta1, Tim van Loon1, Joost Lumens2

  • 1Department of Biomedical Engineering, CARIM Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.

PubMed

Insights

Computational models are revolutionizing cardiovascular medicine by integrating patient data for personalized care. These tools enhance diagnostics, deepen understanding of heart disease, and enable tailored treatments for better patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Computational Biology
  • Biomedical Engineering

Background:

  • Cardiovascular disease (CVD) is a major global health burden.
  • Standardized treatments often fail to account for individual patient variability.
  • Computational models offer a path toward personalized cardiovascular care.

Purpose of the Study:

  • To review the evolution of computational modeling in cardiovascular medicine.
  • To explore applications in diagnostics, mechanistic insights, and precision medicine.
  • To highlight the complementary roles of data-driven and knowledge-driven models.

Main Methods:

  • Review of current literature on computational cardiovascular modeling.
  • Analysis of applications including AI-guided measurements, model-informed diagnostics, and digital twins.
  • Discussion of knowledge-driven and data-driven modeling approaches.

Main Results:

  • Computational models are transitioning from research tools to clinical decision support systems.
  • Applications include enhanced diagnostic accuracy and patient-specific simulations for therapeutic testing.
  • Both data-driven and knowledge-driven models offer unique strengths for CVD management.

Conclusions:

  • Computational models hold significant potential for advancing personalized cardiovascular care.
  • Interdisciplinary collaboration, pragmatic design, and hybrid approaches are crucial for future development.
  • Challenges in validation, regulation, and clinical integration need to be addressed.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
343
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
416
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.4K